- Home
- OFLX vs NERV Comparison
OFLX vs NERV Comparison
Compare OFLX & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OFLX | NERV |
|---|---|---|
| Founded | 1975 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.0M | 269.6M |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OFLX | NERV |
|---|---|---|
| Price | $28.99 | $7.75 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 37.1K | ★ 189.4K |
| Earning Date | 06-12-2026 | 07-06-2026 |
| Dividend Yield | ★ 4.73% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $98,296,000.00 | $41,175,600.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.56 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.58 | $1.15 |
| 52 Week High | $39.98 | $12.46 |
Technical Indicators
Market Signals| Indicator | OFLX | NERV |
|---|---|---|
| Relative Strength Index (RSI) | 30.83 | 65.66 |
| Support Level | $26.50 | $5.34 |
| Resistance Level | $29.54 | $12.46 |
| Average True Range (ATR) | 1.76 | 0.71 |
| MACD | -0.59 | 0.04 |
| Stochastic Oscillator | 16.07 | 71.96 |
Price Performance
Historical ComparisonAbout OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.